Journal of Medicinal Chemistry · 2017 · 34 citations · 26 references
PharmacyMedicinal ChemistryPharmacologyDrug DesignDrug DiscoveryStructure-activity RelationshipsDrug-receptor InteractionsLigand BindingLigand-based DesignMulti-target Drug DesignQuantitative Structure-activity RelationshipsStructure-activity Relationship AnalysisActivitiesCompulsive DisordersDopamine Receptor SubtypesEndocannabinoid SystemStructure - Activity Relationship OptimizationStructure-activity Relationship ModelingStructure-based Ligand DesignStructure-based Multi-target Design
We recently reported molecules designed according to the multitarget-directed ligand paradigm to exert combined activity at human fatty acid amide hydrolase (FAAH) and dopamine receptor subtype D3 (D3R). Both targets are relevant for tackling several types of addiction (most notably nicotine addiction) and other compulsive behaviors. Here, we report an SAR exploration of a series of biphenyl- N -[4-[4-(2,3-substituted-phenyl)piperazine-1-yl]alkyl]carbamates, a novel class of molecules that had shown promising activities at the FAAH–D3R target combination in preliminary studies. We have rationalized the structural features conducive to activities at the main targets and investigated activities at two off-targets: dopamine receptor subtype D2 and endocannabinoid receptor CB 1. To understand the unexpected affinity for the CB 1 receptor, we devised a 3D-QSAR model, which we then prospectively validated. Compound 33 was selected for PK studies because it displayed balanced affinities for the main targets and clear selectivity over the two off-targets. 33 has good stability and oral bioavailability and can cross the blood–brain barrier.
26
QSAR Modeling: Where Have You Been? Where Are You Going To?
Artem Cherkasov, Eugene Muratov, Denis Fourches et al. · Journal of Medicinal Chemistry · 2013 · 2.1K citations
Modulation of anxiety through blockade of anandamide hydrolysis
Satish Kathuria, Silvana Gaetani, Darren Fegley et al. · Nature Medicine · 2002 · 1.3K citations · Full text
Medicine, Neuroscience, Pharmacology +12
Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
Ellen Y. T. Chien, Wei Liu, Qiang Zhao et al. · Science · 2010 · 1.1K citations